【华领医药-B(02552.HK)授出20万份购股权】智通财经APP讯，华领医药-B(02552.HK)发布公告，于2026年8月21日，本公司根据于2018年8月26日有条件批准及采纳，并于2018年9月14日起生效的本公司购股权计划，向本公司一名雇员(承授人)授出20万份购股权，惟须待承授人接纳后方可作实。购股权赋予承授人权利可认购本公司股本中合共20万股每股面值0.001美元的新股份。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.